Dr. Ward received medical training at McGill, University of London and Johns Hopkins (Internal Medicine, Tropical Medicine, Infectious Diseases & Microbiology). His research training began as a Rhodes scholar (1977-1980) and continued at Johns Hopkins (1986-1990). He joined the McGill Medical faculty in 1991 where he is currently full professor. He is chair of CAIRE(Canadian Association for Immunization Research and Evaluation) and represents Canada/CIHR on the GloPID-RScientific Advisory Board (Global Infectious Diseases Preparedness Research). He also sits on the Institutional Advisory Board of the CIHR Institute for Health Promotion & Prevention. Since 2010 and 2015 respectively, he has served as Medical Officer for Medicago, a rapidly growing company using plants to make vaccines and Aviex, a smaller US company using attenuated Salmonella strains as vaccine vectors. His research interests include nanoparticle vaccines, adjuvants & immunomodulators, micronutrient-virus interactions, and parasite diagnostics. He has published >225 peer-reviewed manuscripts/chapters and is a fellow of the Canadian Academy of Health Sciences. His international work has been carried out with colleagues in Peru, Zimbabwe, Sudan, Haiti and Venezuela among other countries.
Immunogenicity of a plant-derived quadrivalent VLP vaccine in adults and the elderly
· Phase 2 clinical results on QIV seasonal VLPs in healthy adults and elderly
· Comparison of humoral and cell-mediated immune responses induced by VLPs